ESTHMR إستثمر

GlaxoSmithKline S.A.E. BIOC

جلاكسو سميثكلاين

Health Care & PharmaceuticalsEgyptian Exchange

421.01 EGP

-4.32%

Close of Thu 12 Nov 2026

Market value
EGP 36.02bn
Highest and lowest close in a year
58.03 – 550.00
Shares traded in the session
1,056,422
Open the full company record in ESTHMR

A chart of every session, the financial statements, the nine checks and filing alerts. Free, with your e-mail and a six-digit code.

About the company

GlaxoSmithKline S.A.E. is a Cairo-based pharmaceuticals company operating in the Pharmaceuticals, Biotechnology and Life Sciences sector. Established in January 1981 and incorporated on 14 January 1981, it has been listed on the EGX since October 1985. It is controlled by Glaxo Group Ltd, which holds 91.2%, with Qatar National Bank holding 5.89%. It holds 99.64% of Amoun Pharmaceutical Industries and 20.0% of Modern Pharma International.

Its record at the exchange

Between 2010 and 2026, the company accumulated 524 filings, peaking in 2022 with 45 filings. Its trading was suspended 20 times and resumed 18 times. Across 66 reported periods of financial results from 2013 to 2026, it reported 10 loss-making periods. Net results ranged from a peak net profit of 921 million EGP in 9M 2022 to a low of -131 million EGP in 9M 2015.

Its latest filings at the exchange

  1. ResultsGlaxo Smith Kline (BIOC.CA) Reports 9 Months Consolidated Results
  2. ResultsGlaxo Smith Kline (BIOC.CA) Reports 9 Months Standalone Results
  3. Board decisionsGlaxo Smith Kline (BIOC.CA) - Summary of Board of Directors' Decisions
  4. Release from Glaxo Smith Kline (BIOC.CA) Concerning the Board of Directors & the Executive Managers
  5. Shareholders' meetingGlaxo Smith Kline (BIOC.CA) - EGM Invitation
  6. Glaxo Smith Kline (BIOC.CA) Declares Cash Dividends
  7. Regulator statementGlaxo Smith Kline (BIOC.CA) - Release from the Financial Regulatory Authority
  8. Board decisionsGlaxo Smith Kline (BIOC.CA) - Disclosure Form for the BoD & the Shareholders' Structure

Insider trades in the exchange’s bulletin

As the exchange publishes them in each session’s bulletin: the trader’s capacity, not their name. Each row opens the bulletin itself.

No insider trades in the company in the exchange bulletins we have read.

Other companies in Health Care & Pharmaceuticals

Page updated with the data of 15 Nov 2026.